Usability and consistency of harm information in drug product descriptions: a matched comparison of data between the United States (US) and Europe

Ítems similars

• Core harm outcome sets developed by drug are needed to allow informed risk-benefit decision making
  per: Cornelius, Victoria, et al.
  Publicat: (2015)
• Variation in adverse drug reactions listed in product information for antidepressants and anticonvulsants, between the USA and Europe: a comparison review of paired regulatory documents
  per: Cornelius, Victoria R, et al.
  Publicat: (2016)
• Making core outcomes more clinically meaningful: 2-for-the-price-of-1 with a distributional approach
  per: Peacock, Janet L, et al.
  Publicat: (2015)
• Adverse event reporting in randomised trials of neuropathic pain: challenges for clinical usefulness of safety data
  per: Cornelius, Victoria R, et al.
  Publicat: (2011)
• Making continuous outcomes meaningful to clinicians
  per: Peacock, Janet L, et al.
  Publicat: (2011)